Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
SNSE on Nasdaq
Shares outstanding
1,272,828
Price per share
$9.66
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
48,247
Total reported value
$514,780
% of total 13F portfolios
0%
Share change
-1,088
Value change
-$10,572
Number of holders
10
Price from insider filings
$9.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Trails Edge Capital Partners, LP 9.9% $1,217,257 126,010 Trails Edge Capital Partners, LP 18 Feb 2026

As of 31 Dec 2025, 10 institutional investors reported holding 48,247 shares of Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE). This represents 3.8% of the company’s total 1,272,828 outstanding shares.

Institutional Holders of Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 48,247 $514,780 -$10,572 $10.67 10
2025 Q3 49,335 $466,215 -$168,686 $9.45 9
2025 Q2 69,928 $599,982 +$593,398 $8.58 10
2025 Q1 16,514 $6,507 +$6,507 $0.39 1